Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
287 hedge funds and large institutions have $3.02B invested in Amedisys in 2023 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 111 increasing their positions, 82 reducing their positions, and 39 closing their positions.
35% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 82
18% more funds holding in top 10
Funds holding in top 10: 11 → 13 (+2)
10% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 39
8% more capital invested
Capital invested by funds: $2.79B → $3.02B (+$225M)
6.7% more ownership
Funds ownership: 90.64% → 97.34% (+6.7%)
0% more funds holding
Funds holding: 286 → 287 (+1)
79% less call options, than puts
Call options by funds: $18.2M | Put options by funds: $88.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$122M |
| 2 |
WIC
Water Island Capital
New York
|
+$43.1M |
| 3 |
Millennium Management
New York
|
+$35.5M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$33.4M |
| 5 |
SCM
Segantii Capital Management
Hong Kong
|
+$32.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$91.6M |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$34M |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
-$30.5M |
| 4 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$29.4M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$15.8M |
AMED Hedge Fund Activity: Q4 2023 in Review
287 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2023, worth a combined $3.02B — up 8.1% from $2.79B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new AMED positions and 39 closed out — a net gain of 4 holders — while 111 added to existing stakes and 82 trimmed.
The largest buyer was Fidelity International, opening a new position worth an estimated $122M. The largest seller was Wellington Management Group, exiting entirely with an estimated $91.6M sold.
- 287 institutional investors held Amedisys (AMED) as of Q4 2023, up from 286 in Q3 2023.
- Funds reported $3.02B of Amedisys stock for Q4 2023, up 8.1% quarter-over-quarter.
- 43 funds opened new Amedisys positions in Q4 2023 and 39 closed out, a net change of +4 holders.
- The largest Amedisys buyer in Q4 2023 was Fidelity International, an estimated $122M added.
- The largest Amedisys seller in Q4 2023 was Wellington Management Group, an estimated $91.6M sold.
Based on aggregated 13F filings for Q4 2023.